Camostat (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Camostat" in Italian language version.

refsWebsite

Global rank Italian rank

7doi.org

2^nd place

7^th place

7nih.gov

4^th place

9^th place

5oadoi.org

799^th place

22^nd place

1chemicalbook.com

low place

1quifinanza.it

low place

2,763^rd place

1web.archive.org

1^st place

1selleckchem.com

low place

chemicalbook.com

Camostat mesilate | 59721-29-8, su chemicalbook.com. URL consultato il 16 marzo 2020.

doi.org

dx.doi.org

M. Okuno, S. Kojima, K. Akita, R. Matsushima-Nishiwaki, S. Adachi, T. Sano, Y. Takano, K. Takai, A. Obora, I. Yasuda, Y. Shiratori, Y. Okano, J. Shimada, Y. Suzuki, Y. Muto e Y. Moriwaki, Retinoids in liver fibrosis and cancer, in Frontiers in Bioscience, vol. 7, n. 4, 2002, pp. d204-18, DOI:10.2741/A775, PMID 11779708.
H. P. Hsieh e J. T. Hsu, Strategies of development of antiviral agents directed against influenza virus replication, in Current Pharmaceutical Design, vol. 13, n. 34, 2007, pp. 3531–42, DOI:10.2174/138161207782794248, PMID 18220789.
K. Kitamura e K. Tomita, Proteolytic activation of the epithelial sodium channel and therapeutic application of a serine protease inhibitor for the treatment of salt-sensitive hypertension, in Clinical and Experimental Nephrology, vol. 16, n. 1, 2012, pp. 44–8, DOI:10.1007/s10157-011-0506-1, PMID 22038264.
Y. Zhou, P. Vedantham, K. Lu, J. Agudelo, R. Carrion Jr, J. W. Nunneley, D. Barnard, S. Pöhlmann, J. H. McKerrow, A. R. Renslo e G. Simmons, Protease inhibitors targeting coronavirus and filovirus entry, in Antiviral Research, vol. 116, 2015, pp. 76–84, DOI:10.1016/j.antiviral.2015.01.011, PMC 4774534, PMID 25666761.
M. Ueda, K. Uchimura, Y. Narita, Y. Miyasato, T. Mizumoto, J. Morinaga, M. Hayata, Y. Kakizoe, M. Adachi, T. Miyoshi, N. Shiraishi, D. Kadowaki, Y. Sakai, M. Mukoyama e K. Kitamura, The serine protease inhibitor camostat mesilate attenuates the progression of chronic kidney disease through its antioxidant effects, in Nephron, vol. 129, n. 3, 2015, pp. 223–32, DOI:10.1159/000375308, PMID 25766432.
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, in Cell, March 2020, DOI:10.1016/j.cell.2020.02.052, PMID 32142651.
Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N, TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection, in J. Virol., vol. 93, n. 6, March 2019, DOI:10.1128/JVI.01815-18, PMC 6401451, PMID 30626688.

nih.gov

ncbi.nlm.nih.gov

M. Okuno, S. Kojima, K. Akita, R. Matsushima-Nishiwaki, S. Adachi, T. Sano, Y. Takano, K. Takai, A. Obora, I. Yasuda, Y. Shiratori, Y. Okano, J. Shimada, Y. Suzuki, Y. Muto e Y. Moriwaki, Retinoids in liver fibrosis and cancer, in Frontiers in Bioscience, vol. 7, n. 4, 2002, pp. d204-18, DOI:10.2741/A775, PMID 11779708.
H. P. Hsieh e J. T. Hsu, Strategies of development of antiviral agents directed against influenza virus replication, in Current Pharmaceutical Design, vol. 13, n. 34, 2007, pp. 3531–42, DOI:10.2174/138161207782794248, PMID 18220789.
K. Kitamura e K. Tomita, Proteolytic activation of the epithelial sodium channel and therapeutic application of a serine protease inhibitor for the treatment of salt-sensitive hypertension, in Clinical and Experimental Nephrology, vol. 16, n. 1, 2012, pp. 44–8, DOI:10.1007/s10157-011-0506-1, PMID 22038264.
Y. Zhou, P. Vedantham, K. Lu, J. Agudelo, R. Carrion Jr, J. W. Nunneley, D. Barnard, S. Pöhlmann, J. H. McKerrow, A. R. Renslo e G. Simmons, Protease inhibitors targeting coronavirus and filovirus entry, in Antiviral Research, vol. 116, 2015, pp. 76–84, DOI:10.1016/j.antiviral.2015.01.011, PMC 4774534, PMID 25666761.
M. Ueda, K. Uchimura, Y. Narita, Y. Miyasato, T. Mizumoto, J. Morinaga, M. Hayata, Y. Kakizoe, M. Adachi, T. Miyoshi, N. Shiraishi, D. Kadowaki, Y. Sakai, M. Mukoyama e K. Kitamura, The serine protease inhibitor camostat mesilate attenuates the progression of chronic kidney disease through its antioxidant effects, in Nephron, vol. 129, n. 3, 2015, pp. 223–32, DOI:10.1159/000375308, PMID 25766432.
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, in Cell, March 2020, DOI:10.1016/j.cell.2020.02.052, PMID 32142651.
Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N, TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection, in J. Virol., vol. 93, n. 6, March 2019, DOI:10.1128/JVI.01815-18, PMC 6401451, PMID 30626688.

oadoi.org

M. Okuno, S. Kojima, K. Akita, R. Matsushima-Nishiwaki, S. Adachi, T. Sano, Y. Takano, K. Takai, A. Obora, I. Yasuda, Y. Shiratori, Y. Okano, J. Shimada, Y. Suzuki, Y. Muto e Y. Moriwaki, Retinoids in liver fibrosis and cancer, in Frontiers in Bioscience, vol. 7, n. 4, 2002, pp. d204-18, DOI:10.2741/A775, PMID 11779708.
H. P. Hsieh e J. T. Hsu, Strategies of development of antiviral agents directed against influenza virus replication, in Current Pharmaceutical Design, vol. 13, n. 34, 2007, pp. 3531–42, DOI:10.2174/138161207782794248, PMID 18220789.
K. Kitamura e K. Tomita, Proteolytic activation of the epithelial sodium channel and therapeutic application of a serine protease inhibitor for the treatment of salt-sensitive hypertension, in Clinical and Experimental Nephrology, vol. 16, n. 1, 2012, pp. 44–8, DOI:10.1007/s10157-011-0506-1, PMID 22038264.
M. Ueda, K. Uchimura, Y. Narita, Y. Miyasato, T. Mizumoto, J. Morinaga, M. Hayata, Y. Kakizoe, M. Adachi, T. Miyoshi, N. Shiraishi, D. Kadowaki, Y. Sakai, M. Mukoyama e K. Kitamura, The serine protease inhibitor camostat mesilate attenuates the progression of chronic kidney disease through its antioxidant effects, in Nephron, vol. 129, n. 3, 2015, pp. 223–32, DOI:10.1159/000375308, PMID 25766432.
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, in Cell, March 2020, DOI:10.1016/j.cell.2020.02.052, PMID 32142651.

quifinanza.it

Coronavirus, farmaci utili a combatterlo in attesa del vaccino, su quifinanza.it, QuiFinanza, 10 marzo 2020. URL consultato il 16 marzo 2020.

selleckchem.com

Camostat Mesilate | ≥99%(HPLC) | Selleck | Sodium Channel inhibitor, su selleckchem.com. URL consultato il 16 marzo 2020.

web.archive.org

(EN) Markus Hoffman, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, su Cell, 5 marzo 2020. URL consultato il 17 marzo 2021 (archiviato dall'url originale il 14 aprile 2020).